Concise Review: Mesenchymal Stem Cells: From Roots to Boost
- PMID: 30977255
- PMCID: PMC6658105
- DOI: 10.1002/stem.3016
Concise Review: Mesenchymal Stem Cells: From Roots to Boost
Abstract
It was shown as long as half a century ago that bone marrow is a source of not only hematopoietic stem cells, but also stem cells of mesenchymal tissues. Then the term "mesenchymal stem cells" (MSCs) was coined in the early 1990s, and more than a decade later, the criteria for defining MSCs have been released by the International Society for Cellular Therapy. The easy derivation from a variety of fetal and adult tissues and undemanding cell culture conditions made MSCs an attractive research object. It was followed by the avalanche of reports from preclinical studies on potentially therapeutic properties of MSCs, such as immunomodulation, trophic support and capability for a spontaneous differentiation into connective tissue cells, and differentiation into the majority of cell types upon specific inductive conditions. Although ontogenesis, niche, and heterogeneity of MSCs are still under investigation, there is a rapid boost of attempts at clinical applications of MSCs, especially for a flood of civilization-driven conditions in so quickly aging societies, not only in the developed countries, but also in the populous developing world. The fields of regenerative medicine and oncology are particularly extensively addressed by MSC applications, in part due to the paucity of traditional therapeutic options for these highly demanding and costly conditions. There are currently almost 1,000 clinical trials registered worldwide at ClinicalTrials.gov, and it seems that we are starting to witness the snowball effect with MSCs becoming a powerful global industry; however, the spectacular effects of MSCs in the clinic still need to be shown. Stem Cells 2019;37:855-864.
Keywords: Clinical; Differentiation; History; Immunomodulation; Mesenchymal stem cells; Paracrine activity.
© AlphaMed Press 2019.
Figures
Similar articles
-
Clinical Trials With Mesenchymal Stem Cells: An Update.Cell Transplant. 2016;25(5):829-48. doi: 10.3727/096368915X689622. Epub 2015 Sep 29. Cell Transplant. 2016. PMID: 26423725 Review.
-
Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.Int J Mol Sci. 2020 Nov 7;21(21):8366. doi: 10.3390/ijms21218366. Int J Mol Sci. 2020. PMID: 33171878 Free PMC article. Review.
-
An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine.Mol Biol Rep. 2020 Mar;47(3):2381-2389. doi: 10.1007/s11033-020-05298-6. Epub 2020 Feb 6. Mol Biol Rep. 2020. PMID: 32026284 Review.
-
Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.Cell Transplant. 2016;25(5):849-61. doi: 10.3727/096368916X690881. Epub 2016 Feb 15. Cell Transplant. 2016. PMID: 26884346 Review.
-
Automated digital image quantification of histological staining for the analysis of the trilineage differentiation potential of mesenchymal stem cells.Stem Cell Res Ther. 2019 Feb 26;10(1):69. doi: 10.1186/s13287-019-1170-8. Stem Cell Res Ther. 2019. PMID: 30808403 Free PMC article.
Cited by
-
Crosstalk Between Mesenchymal Stromal Cells and Chondrocytes: The Hidden Therapeutic Potential for Cartilage Regeneration.Stem Cell Rev Rep. 2021 Oct;17(5):1647-1665. doi: 10.1007/s12015-021-10170-6. Epub 2021 May 5. Stem Cell Rev Rep. 2021. PMID: 33954877 Review.
-
Functionalized Silica Star-Shaped Nanoparticles and Human Mesenchymal Stem Cells: An In Vitro Model.Nanomaterials (Basel). 2021 Mar 18;11(3):779. doi: 10.3390/nano11030779. Nanomaterials (Basel). 2021. PMID: 33803869 Free PMC article.
-
Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis.Front Immunol. 2024 Jan 30;15:1338744. doi: 10.3389/fimmu.2024.1338744. eCollection 2024. Front Immunol. 2024. PMID: 38352879 Free PMC article. Review.
-
Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification.Elife. 2022 Dec 29;11:e81290. doi: 10.7554/eLife.81290. Elife. 2022. PMID: 36579892 Free PMC article.
-
Challenges of Gene Editing Therapies for Genodermatoses.Int J Mol Sci. 2023 Jan 24;24(3):2298. doi: 10.3390/ijms24032298. Int J Mol Sci. 2023. PMID: 36768619 Free PMC article. Review.
References
-
- Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230–247. - PubMed
-
- Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393–403. - PubMed
-
- Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974;17:331–340. - PubMed
-
- Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641–650. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources